Taiwan Severe Cutaneous Adverse Reaction Consortium Selected Research

Taiwan Severe Cutaneous Adverse Reaction Consortium Research Topics

3	Drug Hypersensitivity Syndrome 01/2022 - 01/2016
3	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2017 - 08/2014
2	Cicatrix (Scar) 01/2023 - 03/2021
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 01/2018
2	Hypersensitivity (Allergy) 01/2018 - 01/2016
2	Exanthema (Rash) 01/2016 - 08/2014
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2023
1	Septic Shock (Toxic Shock Syndrome) 09/2022
1	Mycoplasma Infections 09/2022
1	Shock 09/2022
1	Acute Kidney Injury (Acute Renal Failure) 09/2022
1	Disseminated Intravascular Coagulation 06/2021
1	Leprosy (Hansen's Disease) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2016
1	Hyperuricemia 01/2016
1	Eosinophilia 08/2014

3	HLA-B Antigens (HLA-B)IBA 01/2022 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2022
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 09/2022 - 01/2017
2	HLA-A Antigens (HLA-A)IBA 01/2022 - 03/2021
1	Genetic Markers (Genetic Marker)IBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Amoxicillin (Wymox)FDA LinkGeneric 09/2022
1	Vancomycin FDA LinkGeneric 01/2022
1	ProcalcitoninIBA 06/2021
1	strontium ranelate (protelos)IBA 03/2021
1	Dapsone FDA Link 01/2018
1	Allopurinol (Remid)FDA LinkGeneric 01/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 08/2014
1	Phenytoin (Dilantin)FDA LinkGeneric 08/2014

1	Transcutaneous Electric Nerve Stimulation (TENS) 09/2022